Hjem › Neuroblastom › Utah › Salt Lake City
Kliniske studier for Neuroblastom i Salt Lake City, UT
6 studier for Neuroblastom søker deltakere på steder i og rundt Salt Lake City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RekruttererFase 3
- Primary Children's Hospital, Salt Lake City
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RekruttererFase 1/2
- Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Primary Children's Hospital, Salt Lake City
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RekruttererFase 3
- Primary Children's Hospital, Salt Lake City
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
RekruttererFase 1/2
- University of Utah Hospital, Salt Lake City
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RekruttererFase 2
- Primary Children's Hospital, Salt Lake City
Neuroblastom-studier i andre byer
- Boston, MA13 studier
- Washington, DC11 studier
- New York City, NY10 studier
- St. Louis, MO9 studier
- Dallas, TX9 studier
- Memphis, TN9 studier
- Philadelphia, PA9 studier
- Hartford, CT8 studier
- Birmingham, AL8 studier
- Minneapolis, MN8 studier
- Aurora, CO8 studier
- Miami, FL7 studier
Andre studier i Salt Lake City
- Ikke-småcellet lungekreft31 studier
- Kreft (alle typer)27 studier
- Brystkreft27 studier
- Kolorektal kreft22 studier
- Lungekreft21 studier
- Melanom21 studier
- Multipelt myelom21 studier
- Metastatisk kreft20 studier
- Eggstokkreft19 studier
- Fedme18 studier
- Akut myelogen leukemi17 studier
- Hjertesvikt17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.